-+ 0.00%
-+ 0.00%
-+ 0.00%

Medpace Holdings Raises FY2026 GAAP EPS Guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 Est; Narrows FY2026 Sales Guidance from $2.805B-$2.885B to $2.835B-$2.855B vs $2.851B Est

Benzinga·10/21/2026 20:19:09
Listen to the news
Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 analyst estimate. Narrows FY2026 sales outlook from $2.805 billion-$2.885 billion to $2.835 billion-$2.855 billion vs $2.851 billion estimate.